当前位置:首页 - 行情中心 - 丸美生物(603983) - 财务分析 - 现金流量表

丸美生物

(603983)

  

流通市值:160.20亿  总市值:160.20亿
流通股本:4.01亿   总股本:4.01亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,731,392,482.43940,368,885.052,741,264,907.11,894,127,995.77
  收到的税费返还51,130.7420,438.86263,067.9356,839.25
  收到其他与经营活动有关的现金44,247,489.713,667,503.4936,111,466.4326,113,408.89
  经营活动现金流入小计1,775,691,102.87954,056,827.42,777,639,441.461,920,298,243.91
  购买商品、接受劳务支付的现金596,515,187.7320,428,057.22801,482,128.47645,720,251.44
  支付给职工以及为职工支付的现金131,348,731.7569,571,611.7233,357,322.12168,194,274.53
  支付的各项税费147,798,515.6666,211,607.23257,263,281.62148,081,018.97
  支付其他与经营活动有关的现金784,381,420.61525,433,112.521,185,009,850.91889,879,188.48
  经营活动现金流出的平衡项目00-0.010
  经营活动现金流出小计1,660,043,855.72981,644,388.672,477,112,583.111,851,874,733.42
  经营活动产生的现金流量净额115,647,247.15-27,587,561.27300,526,858.3568,423,510.49
二、投资活动产生的现金流量:
  收回投资收到的现金105,000,00045,739,075.35833,237,428.65698,226,159.88
  取得投资收益收到的现金2,862,510.371,063,408.689,346,601.766,584,216.14
  处置固定资产、无形资产和其他长期资产收回的现金净额--4,082-
  处置子公司及其他营业单位收到的现金净额--3,202,758.55-
  收到的其他与投资活动有关的现金49,467,84049,527,540554,329,379.17347,450,466.67
  投资活动现金流入小计157,330,350.3796,330,024.031,400,120,250.131,052,260,842.69
  购建固定资产、无形资产和其他长期资产支付的现金120,365,414.7869,236,457.12316,374,344.31261,321,506.01
  投资支付的现金115,000,00055,000,000595,000,000445,000,000
  支付其他与投资活动有关的现金--56,554,305.5651,554,305.56
  投资活动现金流出小计235,365,414.78124,236,457.12967,928,649.87757,875,811.57
  投资活动产生的现金流量净额平衡项目000.010
  投资活动产生的现金流量净额-78,035,064.41-27,906,433.09432,191,600.27294,385,031.12
三、筹资活动产生的现金流量:
  吸收投资收到的现金--2,000,0002,000,000
  其中:子公司吸收少数股东投资收到的现金--2,000,0002,000,000
  取得借款收到的现金--150,000,000377,518,827.78
  收到其他与筹资活动有关的现金415,388,536.34-634,676,783.33-
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计415,388,536.34-786,676,783.33379,518,827.78
  偿还债务支付的现金150,000,000150,000,000248,000,000248,000,000
  分配股利、利润或偿付利息支付的现金200,666,388.19135,416.67314,441,664.99211,982,491.24
  其中:子公司支付给少数股东的股利、利润--1,286,387.22-
  支付其他与筹资活动有关的现金421,884,336.311,497,919.56417,384,135.297,405,652.19
  筹资活动现金流出小计772,550,724.5151,633,336.23979,825,800.28467,388,143.43
  筹资活动产生的现金流量净额-357,162,188.16-151,633,336.23-193,149,016.95-87,869,315.65
四、汇率变动对现金及现金等价物的影响124,244.9820,332.55-48,386.26-35,217.93
  现金及现金等价物净增加额平衡项目00-0.010
五、现金及现金等价物净增加额-319,425,760.44-207,106,998.04539,521,055.4274,904,008.03
  加:期初现金及现金等价物余额1,579,060,009.941,579,060,009.941,039,538,954.541,039,538,954.54
  期末现金及现金等价物余额1,259,634,249.51,371,953,011.91,579,060,009.941,314,442,962.57
补充资料:
  净利润186,042,088.9-342,363,890.32-
  资产减值准备1,349,645.31-12,233,506.16-
  固定资产和投资性房地产折旧8,748,911.36-20,518,008.83-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧8,748,911.36-20,518,008.83-
  无形资产摊销1,866,733.84-4,073,362.03-
  长期待摊费用摊销6,412,402.73-1,433,270.35-
  处置固定资产、无形资产和其他长期资产的损失-377,398.06--29,631.89-
  固定资产报废损失39,562.75-314,782.26-
  公允价值变动损失-587,598.74-982,898.54-
  财务费用2,656,560.66-9,901,066.66-
  投资损失-2,783,249.38--20,024,755.1-
  递延所得税4,941,628.38--35,707,131.13-
  其中:递延所得税资产减少6,466,939.71--32,741,819.61-
    递延所得税负债增加-1,525,311.33--2,965,311.52-
  存货的减少-22,795,755.2--60,163,685.74-
  经营性应收项目的减少-40,739,078.18--41,383,998.97-
  经营性应付项目的增加-29,781,805.72-61,914,325.91-
  其他-428,994.71-542,711.25-
  现金的期末余额1,259,634,249.5-1,579,060,009.94-
  减:现金的期初余额1,579,060,009.94-1,039,538,954.54-
  现金及现金等价物的净增加额-319,425,760.44-539,521,055.4-
公告日期2025-08-232025-04-262025-04-262024-10-26
审计意见(境内)标准无保留意见
TOP↑